2016's Top IPOs
- Acacia Communications (ACIA) 369.91%
- Twilio, Inc. (TWLO) 318.60%
- Impinj (PI) 140.86%
- Clearside Biomedical (CLSD) 117.43%
- Reata Pharmaceuticals, Inc. (RETA) 113.82%
- AveXis (AVXS) 102.75%
- Proteostasis Therapeutics, Inc. (PTI) 92.75%
- TPI Composites (TPIC) 92.45%
- Novan (NOVN) 84.09%
- SiteOne Landscape Supply, Inc. (SITE) 76.19%
On July 1, 2015, the IPO Teladoc, Inc. (NYSE: TDOC) opened for trading at $29.90 after pricing 8,250,000 shares of its common stock at a price to the public of $19.00 per share, above the recently expected range of $15 to $17 per share.
J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. are acting as joint book-running managers for the offering. William Blair & Company, L.L.C., Wells Fargo Securities, LLC and SunTrust Robinson Humphrey, Inc. are acting as co-managers for the offering.
Teladoc is the nation's first and largest telehealth platform, delivering on-demand healthcare anytime, anywhere, via mobile devices, the internet, video and phone.
- Helios and Matheson (HMNY) Files 1.4M Share Common Shelf for Selling Shareholders
- Northwest Biotherapeutics (NWBO) Files $150M Mixed Shelf
- BioPharmX (BPMX) Enters $930k Registered Direct Offering of Common Stock
- Acacia Communications (ACIA) to Offer Up to $450M in Common Stock
- Skyline Medical (SKLN) Files $20M Mixed Securities Shelf
- See More
|9/23/2016||Gridsum Holding||GSUM||6.7 Mil||$13.00||$15.81||21.62%||Goldman Sachs (Asia) L.L.C., Citigroup, and Stifel|
|9/23/2016||AC Immune||ACIU||6 Mil||$11.00||$15.62||42.00%||Credit Suisse Securities (USA) LLC, Jefferies LLC and Leerink Partners LLC|
|9/23/2016||Apptio||APTI||6 Mil||$16.00||$23.14||44.63%||Goldman, Sachs & Co., J.P. Morgan Securities LLC and BofA Merrill Lynch|
|9/23/2016||Valvoline Inc.||VVV||30 Mil||$22.00||$23.22||5.55%||BofA Merrill Lynch, Citigroup, Morgan Stanley|
|9/22/2016||CapStar Financial||CSTR||2.585 Mil||$15.00||$16.25||8.33%||Keefe, Bruyette & Woods, Inc. and Sandler O\'Neill Partners, L.P|
|9/22/2016||e.l.f. Beauty||ELF||8.333 Mil||$17.00||$24.88||46.35%||J.P. Morgan Securities LLC and Morgan Stanley|
|9/21/2016||Novan||NOVN||4.1 Mil||$11.00||$20.25||84.09%||Piper Jaffray|
|9/21/2016||The Trade Desk||TTD||4.667 Mil||$18.00||$27.30||51.67%||Citigroup, Jefferies and RBC|
|9/16/2016||Everbridge||EVBG||7.5 Mil||$12.00||$14.60||21.67%||Credit Suisse and BofA Merrill Lynch|
|9/16/2016||FB Financial Corporation||FBK||5||$19.00||$20.81||9.53%||J.P. Morgan, UBS Investment Bank, Keefe, Bruyette & Woods|
|N/A||Digicel Group Limited||DCEL||124.1 Mil||$13-$16||J.P. Morgan, UBS Investment Bank, Citigroup, Barclays, Credit Suisse|
|N/A||GenSight Biologics S.A.||GNST||4.7 Mil||$13-$15||Leerink Partners, Evercore ISI, Canaccord Genuity|
|N/A||NovoCure Limited||NVCR||N/A||N/A||J.P. Morgan, Deutsche Bank Securities, Evercore ISI, Wells Fargo Securities, JMP Securities, Wedbush PacGrow|
|N/A||Albertsons Companies, Inc.||ABS||65.306 Mil||$23-$26||Goldman, Sachs & Co., BofA Merrill Lynch, Citigroup, Morgan Stanley, Deutsche Bank Securities, Credit Suisse, Barclays, Lazard, Guggenheim Securities, Jefferies, RBC Capital Markets, Wells Fargo Securities, BMO Capital Markets, SunTrust Robinson Humphrey,|
|N/A||Laureate Education||LAUR||N/A||N/A||Credit Suisse, Morgan Stanley, Barclays, J.P. Morgan, BMO Capital Markets, Citigroup, KKR, Goldman, Sachs & Co.|
|N/A||Noble Midstream Partners LP||NBLX||12.5 Mil||$19-$21||Barclays, Baird, J.P. Morgan|
|N/A||First Guaranty Bancshares||FBGI||750K||$21||Sandler O'Neill|
|N/A||Elevate Credit, Inc.||ELVT||N/A||N/A||UBS Investment Bank, Jefferies, Stifel, William Blair, BB&T Capital Markets|
|N/A||AmeriQuest, Inc.||AMQ||N/A||N/A||Raymond James, Stephens, Baird, William Blair|
|N/A||loanDepot, Inc.||LDI||30 Mil||$16-$18||Morgan Stanley, Goldman Sachs, Wells Fargo, Barclays|
Blue Buffalo Pet Products (NASDAQ: BUFF) filed $500M IPO with the SEC. The company plans to list under symbol "BUFF" on the NASDAQ.
The offering is being led by JPMorgan and Citigroup, with Barlcys, Deutsche Bank, Morgan Stanley, Wells Fargo and LOYAL3 Securities also listed in support.
Blue Buffalo Pet Products is the fastest growing major pet food company in the United States, selling dog and cat food made with whole meats, fruits and vegetables, and other high-quality, natural ingredients. BLUE is a billion dollar brand based on sales at retail and is the #1 brand in the Wholesome Natural market segment. They currently have approximately 6% share of the overall pet food industry and feed only 2-3% of the 164 million pets in the United States.